{
    "title": "(OFFICIAL)-UPDATE 2-Japanese drugmaker Eisai's shares drop on report of death in Alzheimer's trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11480415/Eisai-shares-plunge-Tokyo-report-death-Alzheimers-trial.html",
    "date": "2022-11-29",
    "keywords": [
        "eisai",
        "report",
        "trial",
        "drug",
        "biogen",
        "blood",
        "lecanemab",
        "tokyo",
        "tuesday",
        "woman",
        "haemorrhage",
        "use",
        "risk",
        "death",
        "monday",
        "information",
        "nov",
        "drugmaker",
        "co",
        "companys",
        "treatment",
        "brain",
        "partner",
        "inc",
        "stroke",
        "medicine",
        "tissue",
        "plasminogen",
        "activator",
        "tpa",
        "scienceorg",
        "sunday",
        "bleeding",
        "interpretation",
        "factor",
        "patient",
        "crisis",
        "administration",
        "baird",
        "analyst",
        "skorney",
        "note",
        "man",
        "thinner",
        "june",
        "health",
        "journal",
        "stat",
        "october",
        "statement",
        "safety",
        "therapy",
        "overall",
        "privacy",
        "benchmark",
        "nikkei",
        "index",
        "latestage",
        "study",
        "day",
        "cognitive",
        "decline",
        "september",
        "reporting",
        "swift",
        "raghav",
        "mahobe",
        "khushi",
        "mandowara",
        "bengaluru",
        "editing",
        "osterman",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}